VEEV vs CRM

For growth investors, Veeva Systems Inc.

(VEEV) is the stronger pick with 16. 3% revenue growth year-over-year, versus 9. 6% for Salesforce, Inc. (CRM). Salesforce, Inc. (CRM) offers the better valuation at 23. 9x trailing P/E (15. 8x forward), making it the more compelling value choice. Analysts rate Veeva Systems Inc. (VEEV) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Salesforce, Inc.

(CRM) is the cheapest at 23. 9x versus Veeva Systems Inc. at 30. 9x. On forward P/E, Salesforce, Inc. is actually cheaper at 15. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Veeva Systems Inc. wins at 1. 04x versus Salesforce, Inc. 's 1. 29x — a reasonable growth-adjusted valuation.

Over the past 5 years, Salesforce, Inc.

(CRM) delivered a total return of -12. 3%, compared to -35. 3% for Veeva Systems Inc. (VEEV). Over 10 years, the gap is even starker: VEEV returned +519. 4% versus CRM's +154. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Veeva Systems Inc.

(VEEV) is the lower-risk stock at 0. 77β versus Salesforce, Inc. 's 0. 82β — meaning CRM is approximately 6% more volatile than VEEV relative to the S&P 500. On balance sheet safety, Veeva Systems Inc. (VEEV) carries a lower debt/equity ratio of 1% versus 11% for Salesforce, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Veeva Systems Inc.

(VEEV) is pulling ahead at 16. 3% versus 9. 6% for Salesforce, Inc. (CRM). On earnings-per-share growth, the picture is similar: Veeva Systems Inc. grew EPS 25. 9% year-over-year, compared to 22. 6% for Salesforce, Inc.. Over a 3-year CAGR, VEEV leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Veeva Systems Inc.

(VEEV) is the more profitable company, earning 28. 4% net margin versus 18. 0% for Salesforce, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus 21. 5% for CRM. At the gross margin level — before operating expenses — CRM leads at 77. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Veeva Systems Inc. (VEEV) is the more undervalued stock at a PEG of 1. 04x versus Salesforce, Inc. 's 1. 29x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Salesforce, Inc. (CRM) trades at 15. 8x forward P/E versus 19. 0x for Veeva Systems Inc. — 3. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VEEV: 66. 5% to $280. 10.

In this comparison, CRM (0.

9% yield) pays a dividend. VEEV does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Salesforce, Inc.

(CRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 9% yield, +154. 6% 10Y return). Both have compounded well over 10 years (CRM: +154. 6%, VEEV: +519. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VEEV (Healthcare) and CRM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VEEV is a mid-cap high-growth stock; CRM is a mid-cap quality compounder stock. CRM pays a dividend while VEEV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.